Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Powerful Medical Receives FDA De Novo Approval for PMcardio "Queen of Hearts," Its AI ...

15 September 2026 · By · Wire by Fusion42

Published

15 September 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at businesswire.com →

◆ Verified

Fusion42 · 15 September 2026 · Fusion42 review

Powerful Medical has received FDA De Novo authorization for its AI ECG solution, Queen of Hearts, designed to detect acute heart attacks requiring urgent cardiologist intervention and enable rapid deployment across U.S. health systems.

This Wire brief sits within Fusion42's coverage of Digital Health, and 3 sources have reported it between 7 Sep 2026 and 15 Sep 2026.

◆ ◆ The Wire takeaway

Your cardiac AI startup now faces a new benchmark as FDA opens the door for AI ECG tools in acute care. Rapid adoption in US hospitals means you must accelerate clinical validation and integration to compete.

◆ Coverage

3 sources · first reported 7 Sep 2026 · latest 15 Sep 2026

◆ Related on Wire

◆ Topics

Digital Healthfda-approvalai-ecgcardiovascularhealthtechus-market